Pulmonary Arterial Hypertension Market to reach a valuation of US$5.19 Bn by 2020, Says TMR
July 24, 2018 07:27 ET
|
Transparency Market Research
Albany, NY, July 24, 2018 (GLOBE NEWSWIRE) -- According to TMR, the global pulmonary arterial hypertension therapeutics market is expected to reach a valuation of US$ 5.19 bn by the end of 2020. The...